Malacca, Malaysia – On October 19-20, 2024, Gene Solutions Malaysia joined the National Cancer Society Malaysia (NCSM) and the Malaysian Medical Association (MMA) for a significant roadshow in Malacca. With the theme “Breaking Barriers in Cancer: A Community Symposium,” this two-day event brought together the public and healthcare professionals (HCPs) to explore the latest insights in cancer awareness, screening, and prevention.
Day 1: Empowering the Public through Knowledge
Day one of the roadshow was dedicated to the public, where Mr Raja Iswara, Commercial Director of GS Malaysia, led a session on “Screening & Early Detection of Cancer at the Primary Care Level.” The session welcomed 20 participants, each gaining valuable knowledge on the role of early detection and the preventive steps accessible to them. Raja Iswara’s insights left attendees empowered, underscoring the importance of vigilance in health monitoring and routine screenings.
Day 2: Addressing Healthcare Challenges in Cancer Screening
The second day shifted the focus to healthcare professionals. Dr. Ahmad Rudhzaini, Medical Science Liaison at GS Malaysia, presented on “Cancer Screening & Diagnosis in the Malaysian Context: Challenges, Opportunities, and Solutions.” With 12 dedicated HCPs in attendance, Dr. Ahmad highlighted the unique challenges in cancer diagnostics across Malaysia, sparking discussions on innovative approaches and potential solutions to improve early cancer diagnosis.
Bringing Communities Together for a Shared Cause
Through this collaboration, Gene Solutions Malaysia, NCSM, and MMA succeeded in fostering a meaningful exchange of knowledge and strategies in the battle against cancer. Together, we reinforced the message that awareness, early detection, and shared commitment are essential to overcoming the barriers faced in cancer care today.
About Gene Solutions Malaysia
Gene Solutions established its operations and services in Malaysia in 2023 and is committed to provide the local community access to next-generation genetic tests that support reproductive health and clinical oncology. In the field of clinical oncology, personalized minimal residual disease (MRD) detection, and multi-cancer early detection (MCED) tests using advanced ctDNA technology are among some of the products available. Partnering with local laboratory partners Premier Integrated Lab and Innoquest Malaysia, Gene Solutions Malaysia is committed to enhancing healthcare with their innovative genetic solutions.
